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-
studies, collaborating with investigators
from Cornell University and Case Western
Reserve University.
In these experiments, Yang gave a
group of mice only tea to drink, and he
also gave them, as well as a control group,
chemicals known to produce different can-
cers. Among the animal "tea" models he
has developed are those for lung,
esophageal, and forestomach. He found
that mice fed tea developed fewer tumors
than the control group and that their
tumors were smaller. His latest study on
tea's protective effect on skin cancer was
published inJuly in CancerResearch.
Although there are numerous theories
as to why tea may offer protection, most
scientists think it is due to polyphenols,
such as flavanols, which make up 30% of
the dry weight of the tea. These chemicals
not only possess strong antioxidant activi-
ties, but they can also inhibit nitrosation
reactions, modulate carcinogen-metaboliz-
ing enzymes, trap carcinogens, and inhibit
cell proliferation.
Yang said that he can demonstrate that
tea scavenges free radicals produced by oxi-
dation reactions in the body, "but whether
that is at the heart ofthe anticancer action
remains to be studied." He co-authored a
major review discussing the contradictions
in the study of tea and cancer, published
last July in the Journal ofthe National
Cancer Institute. "It will be very difficult to
pinpoint how it works in humans," said
Yang. "The protective effects may be small
in humans; it may just get lost in a host of
other mechanisms."
To help point to an answer, Yang is
working with the Beijing Cancer Institute
to design an intervention study in China.
It will follow thousands ofpeople who will
take capsules of tea powder daily to see if
the rate ofstomach cancer that develops in
this population is reduced.
Bernard Goldstein, director of the
Environmental and Occupational Health
Sciences Center in NewJersey, welcomed a
renewed interest in tea, which he first stud-
ied 20 years ago. "The studies in animals
are very encouraging," he said, "and there
is enough information about the effect of
tea in humans that it makes one want to
do careful and thorough epidemiological
evaluation."
A Breath of Fresh Air
Flight attendants and passengers may soon
be breathing easier if a bill called the Safe
Cabin Air Quality Act is passed. The bill
(HR 2985), introduced in August 1993 by
Congressman Jerrold Nadler (D-New
York) in response to health complaints
associated with reduced fresh air, would
increase the amount of fresh air pumped
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into airline cabins.
In response to concerns over anticipat-
ed increases in the cost of fuel in the late
1970s, airlines studied ways to conserve
fuel. It was discovered that energy could be
saved by reducing the amounts offresh air
pumped into airplane cabins. For example,
a McDonnell-Douglas study in 1980
found that if the amount of fresh air was
cut by 50% on a DC-10 trip of 1,050
miles, the airline could save 0.8%, or 42
gallons, of fuel. Since the 1980s, the vol-
ume of fresh air circulated in most airline
cabins has been cut by about half from
100% fresh air pumped in every 3 minutes
to halffresh and halfrecirculated air every
6-7 minutes. This drastic reduction has
been blamed for headaches, nausea, dizzi-
ness, and other health problems experi-
enced by flight attendants and passengers.
Chris Witkowski, director ofair safety and
health for theAssociation ofFlight Attend-
ants, says that there are some asthmatics
who will not fly now because ofdifficulties
with breathing. "It's going to be a growing
health problem," he said.
In 1993, using the current domestic
cost of $0.59 per gallon for jet fuel,
Witkowski divided the average number of
passengers on a 1,050 mile trip on a DC-
10 into the price per gallon, multiplied by
42, the number ofestimated gallons offuel
saved, and found that the airlines were sav-
ing $0.13 per passenger. "The average pas-
senger would pay that much to double the
amount of fresh air they get on a flight,"
Witkowski said.
At such a small percentage of savings,
many wonder why airlines would reduce
the amounts of fresh air. Because the
Federal Aviation Administration has failed
to impose guidelines on cabin air quality
standards, airlines have had no disincentive
to save some money. "There is a tendency
for airlines to want to reduce fresh air as
much as possible to squeeze every nickel
out ofthe cost offuel," Witkowski said.
The FAA does regulate the maximum
amount ofcarbon dioxide in airline cabins
at a standard of 30,000 parts per million.
But Witkowski called the figure "absurd,"
and said it is "virtually meaningless at that
level." The level that the American Society
of Heating, Refrigeration, and Air
Conditioning Engineers associates with
satisfaction or comfort is 1,000 ppm. And
the Occupational Safety and Health
Association is considering setting a stan-
dard of800 ppm in workplaces.
Several studies have been done that
link recirculated air to transmission of
viruses and bacteria. Studies by the U.S.
Centers for Disease Control have not been
able to rule out the possibility that tuber-
culosis could be transmitted among pas-
sengers. Last year a report said that a flight
attendant with active tuberculosis infected
13 fellow workers before being diagnosed
and treated. Airlines argue that their filtra-
tion systems mitigate potential exposures,
but a recent study conducted by re-
searchers at the Harvard University School
of Public Health questioned the adequacy
and effectiveness of strategies used by air-
lines. The researchers recommended fur-
ther studies be done before conclusions are
made.
Despite these findings, the Air Trans-
port Association recently concluded that
reducing fresh air in cabins is safe for pas-
sengers and airline crews, outraging airline
flight attendants who want the levels of
fresh air raised. "We feel it is critical for the
federal government to set some standards
for cabin air quality. Until this is done, the
quality of air is going to get worse,"
Witkowski said.
Flight attendants are also urging the
government to take into account the range
of people that travel. Not all airplane pas-
sengers are able-bodied workers; among
those who fly are asthmatics, the elderly,
people with allergies, and people whose
immune systems have been impaired by
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chemotherapy or HIV. Therefore, flight
attendants and others say that airplane
cabin air should be held to higher stan-
dards than workplaces.
Pressure from passengers may be a
major contributing factor in encouraging
airlines to increase fresh air. In the August
issue of Consumer Reports, airlines were
ranked according to levels of carbon diox-
ide in airplane cabins and criticized for the
low amounts offresh air. Consumer Reports
recommended that passengers choose air-
lines according to the amounts offresh air
they circulate. They also recommended
that the FAA set a comfort standard of
1,000 ppm.
Double-Edged Sword?
Although individuals with genetic disor-
ders and diseases such as cancer, AIDS,
diabetes, or Alzheimer's may view the
potential of gene therapy as just the
weapon they're looking for, other people
perceive the "slicing and dicing" ofgenetic
material as a potential double-edged
sword. Scientists are attempting to esti-
mate the real risks associated with gene
therapy.
Most current gene therapies use retro-
viral vectors to transfer a therapeutic gene
into the cells of a patient who lacks a nor-
mally functioning copy of the gene.
Retroviral vectors are made by deleting
portions ofa retroviral genome and replac-
ing the deleted viral genes with the thera-
peutic gene. The resulting vector integrates
a DNA copy ofits genome, containing the
therapeutic gene, into the genome of a
host cell, but because of the missing viral
genes the vector cannot be replicated like a
normal retrovirus.
Typically, bone marrow cells are
removed and exposed to the vector in cul-
ture. The cells containing the therapeutic
gene are then infused back into the
patient. The fear is that the vector may
integrate its DNA copy near a gene
involved in regulation ofgrowth or devel-
opment of the cell and interfere with the
normal regulatory processes, causing the
cell to become cancerous. Although, says
toxicologist Richard Irwin of NIEHS,
"there is absolutely a finite probability
that it will occur," the risk of insertional
mutagenesis is believed to be very low.
The difficulty comes in trying to deter-
mine exactly what "very low" means in
terms of absolute risk to humans from
gene therapy.
Scientists are concerned about other
potential side effects ofthe process ofgene
therapy. First, it is not currently possible to
target a vector carrying a therapeutic gene
to a specific cell population. Expression of
the gene in nontargeted cells may interfere
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with regulation of cell processes or meta-
bolic pathways. Second, the transduced
cells may contain a selective growth advan-
tage, enabling their progeny to predomi-
nate in the host. When such cells are intro-
duced into a patient during gene therapy,
they represent a population carrying a
"first hit" insertional event that may put
the patient at increased risk for additional
mutational events leading potentially to
tumor formation. Third, retroviral vector
preparations may be contaminated by viri-
ons containing packaging cell RNA. In
theory, this RNA could be reverse-tran-
scribed, integrate in the genome of the
recipient cells, and express a product that
could disrupt normal cell functioning.
The risk posed by insertional mutagen-
esis is a particular concern for extending
gene therapy to the treatment of condi-
tions such as diabetes or hemophilia where
substantial numbers of people would be
candidates for the therapy and might be
treated early in their lives. A population of
cells carrying a first hit insertional event
would put such people at an increased risk
throughout the remainder oftheir lives.
As gene therapies are expanded for the
treatment ofmore diseases, the sheer num-
bers ofpeople involved makes it more like-
ly that even a relatively infrequent event
may result in an unacceptably high risk.
Irwin and his colleagues at the NIEHS are
developing studies to attempt to evaluate
the extent of this risk. In these studies,
researchers will expose mice and rats to
retroviral vectors in a number of ways.
These vectors contain marker genes which
allow the researchers to determine the
most effective method ofintegration ofthe
vector into the new cell genome. The ani-
mals are allowed to live out their life spans,
and researchers then examine them to see
if they developed tumors, and if so, if the
tumors contained DNA from the retroviral
vector. The information from these studies
will be used to estimate gene therapy's risk
and may help regulators evaluate the safety
ofcutting edge technology.
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